Keywords: eyetech, sees, 3rd-qtr, net, loss, widen, pharmaceuticals
EyeTech sees 3rd-qtr net loss widen
Article | 01 November 2004
Eyetech Pharmaceuticals of the USA posted a net loss of $24.7 million for the third quarter of 2004, rising 49% over the $16.6 million ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
